Harrow Health Stock Price, News & Analysis
Company Description
Harrow Health (HROWL) is a publicly traded company.
On a trailing twelve-month basis, Harrow Health reported revenue of $272.3M with net income of -$5.1M and diluted earnings per share of $-0.14. The company operates at a net profit margin of -1.9%.
This page provides a comprehensive overview of HROWL stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Latest News
SEC Filings
Harrow Health has filed 5 recent SEC filings, including 3 Form 8-K, 1 Form SCHEDULE 13G/A, 1 Form SCHEDULE 13G. The most recent filing was submitted on March 27, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all HROWL SEC filings →
Financial Highlights
Harrow Health generated $272.3M in revenue over the trailing twelve months, retaining a 75.0% gross margin, operating income reached $30.5M (11.2% operating margin), and net income was -$5.1M, reflecting a -1.9% net profit margin. Diluted earnings per share stood at $-0.14. The company generated $43.9M in operating cash flow. With a current ratio of 2.20, the balance sheet reflects a strong liquidity position.
Upcoming Events
Short Interest History
Short interest in Harrow Health (HROWL) currently stands at 184 shares, up 1000.0% from the previous reporting period. Over the past 12 months, short interest has decreased by 93.1%.
Days to Cover History
Days to cover for Harrow Health (HROWL) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.